Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2006-07-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Systane® Ultra Preservative Free Lubricant Eye Drops
NCT05902364
Trial to Compare the Efficacy of Systane Ultra and Refresh Drop in the Treatment of Dry Eye in Asian Eyes
NCT00796926
A Study to Compare a New Eye Drop Formulation With Refresh Contacts®
NCT01844388
Product Preference With Systane Compared to Artificial Tears on Frequency of Drop Use
NCT00347984
SYSTANE® BALANCE Symptoms (OSDI) & Inflammatory Biomarkers
NCT01733732
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Systane
Systane Free Lubricant Eye Drops
1-2 drops per eye four times per day for 42 days
Refresh
Refresh Liquigel Lubricant Eye Drops
1-2 drops per eye four times per day for 42 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Systane Free Lubricant Eye Drops
1-2 drops per eye four times per day for 42 days
Refresh Liquigel Lubricant Eye Drops
1-2 drops per eye four times per day for 42 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need artificial tears at least some of the time.
Exclusion Criteria
* History of intolerance or hypersensitivity to any component of the study medication.
* Use of Restasis within 30 days of Visit 1.
* Participation in an investigational drug or device study within 30 days of entering this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C-05-45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.